Log in to save to my catalogue

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy bismuth-containing quadru...

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy bismuth-containing quadru...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d9c9c842296a479dbb46d2eb5332ce12

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy bismuth-containing quadruple therapy for infection: a multicenter, randomized controlled clinical trial

About this item

Full title

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy bismuth-containing quadruple therapy for infection: a multicenter, randomized controlled clinical trial

Publisher

SAGE Publishing

Journal title

Therapeutic advances in gastroenterology, 2022-12, Vol.15

Language

English

Formats

Publication information

Publisher

SAGE Publishing

More information

Scope and Contents

Contents

Background: A high-dose proton pump inhibitor (PPI)-amoxicillin dual therapy has been investigated for treatment of patients with Helicobacter pylori ( H. pylori ) infection. Currently, the efficacy of this dual therapy remains inconclusive, with controversial findings from various single-center clinical trials. Objectives: To assess the efficacy a...

Alternative Titles

Full title

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy bismuth-containing quadruple therapy for infection: a multicenter, randomized controlled clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d9c9c842296a479dbb46d2eb5332ce12

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d9c9c842296a479dbb46d2eb5332ce12

Other Identifiers

E-ISSN

1756-2848

DOI

10.1177/17562848221142925

How to access this item